Gut microbiota: a potential target for hyperuricemia and gout DOI Creative Commons
Feiyan Zhao, Shuying Yang, Lai‐Yu Kwok

и другие.

Deleted Journal, Год журнала: 2024, Номер unknown

Опубликована: Июль 1, 2024

Modern lifestyle and diet have increased the incidence rate of uric acid (UA) metabolism-related diseases like hyperuricemia (HUA) gout, posing heavy economic burden to individual patients their families society. Uric metabolism is a complex physiological process involving kidney, intestine, other organs. A number factors together regulate UA metabolism, including genetics, diet, hormones, gut microbiota. This review summaries microbiota features in subjects with HUA therapeutic effects implementing microecological therapies (probiotics, prebiotics, or fecal transplant) that target modulate its downstream on disease. Current evidence shows these strategies are safe promising alleviate inflammation, reduce UA, restoring healthy diseases. However, most clinical data generated by animal studies. Therefore, we propose vigorous human intervention trials should be conducted future evaluate managing gout.

Язык: Английский

Protective Effects of a Polyherbal Mixture on Intestinal Injury via the NF-κB Signaling Pathway and Gut Microbiota Modulation in Hyperuricemic Mice DOI Creative Commons

Haoluan Wang,

Yu Xi, Fei Gu

и другие.

Foods, Год журнала: 2025, Номер 14(7), С. 1118 - 1118

Опубликована: Март 24, 2025

This study investigated the protective effects of a polyherbal tea (PHT) on intestinal injury in hyperuricemia (HUA) mice and underlying mechanisms. PHT was orally administered to for 49 days, while potassium oxonate hypoxanthine were 7 days after administration continued 42 cause HUA. Treatment with significantly reduced serum uric acid blood urea nitrogen levels HUA mice. It also inhibited liver xanthine oxidase activity promoted excretion through upregulation transporters GLUT9 ABCG2. Intestinal barrier integrity reinforced, as evidenced by restoration villous structure, reduction edema, tight junction proteins (occludin, ZO-1) mucin (MUC2). Moreover, suppressed LPS NF-κB pathway, leading TNF-α IL-6 gut. Gut microbiota analysis revealed reversed dysbiosis, enriching beneficial bacteria like Duncaniella sp. Heminiphilus faecis. By UPLC-MS analysis, 154 compounds persisted gut, suggesting that these are likely modulate both function gut microbiota. These findings suggest this may have potential functional food prevention hyperuricemia.

Язык: Английский

Процитировано

0

Effect of Probiotic Product Containing Heyndrickxia coagulans TBC169 on Hyperuricemia in Rats DOI

Lixiao Duan,

Xingting Zhang, Dandan Wang

и другие.

Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown

Опубликована: Март 24, 2025

Язык: Английский

Процитировано

0

Diacylglycerol from camellia oil improves hyperuricemia by inhibiting xanthine oxidase and modulating gut microbiota DOI
Yajuan Chen, Jingjing Xiao, Lingyu Zhang

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142451 - 142451

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Biodegradation of Inosine and Guanosine by Bacillus paranthracis YD01 DOI Open Access

Xinyue Du,

Yao Jiang,

Yawen Sun

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(19), С. 14462 - 14462

Опубликована: Сен. 23, 2023

Both inosine and guanosine are precursors of uric acid that may cause the diseases hyperuricemia gout in humans. Here, a promising bacterial strain for efficiently biodegrading both was successfully isolated from healthy human intestine identified as Bacillus paranthracis YD01 with 16S rRNA analysis. An initial amount 49.6 mg·L−1 or 49.9 completely removed by within 12 h, which showed had strong ability to biodegrade guanosine. Furthermore, 49.2 49.5 totally catalyzed intracellular crude enzymes 6 49.7 biodegraded extracellular 9 h. Illumina Hiseq sequencing database gene annotation were used elucidate genomic characteristics B. YD01. Purine nucleoside phosphorylase, encoded 1785, 3933, 4403, found KEEG database, played crucial role biodegradation The results this study provide valuable insights into mechanisms using

Язык: Английский

Процитировано

7

New drug targets for the treatment of gout arthritis: what’s new? DOI
Tiago H. Zaninelli, Geovana Martelossi-Cebinelli, Telma Saraiva‐Santos

и другие.

Expert Opinion on Therapeutic Targets, Год журнала: 2023, Номер 27(8), С. 679 - 703

Опубликована: Авг. 3, 2023

Introduction Gout arthritis (GA) is an intermittent inflammatory disease affecting approximately 10% of the worldwide population. Symptomatic phases (acute flares) are timely spaced by asymptomatic periods. During acute attack, redness, joint swelling, limited movement, and excruciating pain common symptoms. However, current available therapies not fully effective in reducing symptoms offer numerous side effects. Therefore, unveiling new drug targets effector molecules required developing novel GA therapeutics.

Язык: Английский

Процитировано

6

Screening and evaluation of a novel nucleotide-degrading Levilactobacillus brevis grx821 with anti-hyperuricemia ability DOI
Haiying Wang,

Jiaxing Dai,

Yifeng Han

и другие.

Food Bioscience, Год журнала: 2024, Номер 60, С. 104337 - 104337

Опубликована: Май 15, 2024

Язык: Английский

Процитировано

2

Priestia megaterium ASC-1 Isolated from Pickled Cabbage Ameliorates Hyperuricemia by Degrading Uric Acid in Rats DOI Creative Commons

Wenjuan Zhu,

Siyuan Bi, Zhijia Fang

и другие.

Microorganisms, Год журнала: 2024, Номер 12(4), С. 832 - 832

Опубликована: Апрель 20, 2024

Pickled cabbage, a traditional fermented food rich in functional microorganisms, can effectively control hyperuricemia and gout. In this study, Priestia megaterium ASC-1 strain with strong uric acid (UA) degradation ability was isolated from pickled cabbage. After oral administration for 15 days, stably colonized the rats study. significantly reduced UA levels (67.24%) hyperuricemic rats. Additionally, alleviated hyperuricemia-related inflammatory response, oxidative stress, blood urea nitrogen. Intestinal microbial diversity results showed that restored intestinal injury gut flora dysbiosis caused by hyperuricemia. These findings suggest P. may be used as therapeutic adjuvant treatment of

Язык: Английский

Процитировано

1

Integrated microbiome and metabolome analysis reveals the key role of taurohyocholate in the treatment of hyperuricemia with Lacticaseibacillus rhamnosus 2016SWU.05.0601 DOI
Yanchao Chen, Shihan Yan, Jing Yang

и другие.

Food Research International, Год журнала: 2024, Номер 197, С. 115234 - 115234

Опубликована: Окт. 22, 2024

Язык: Английский

Процитировано

0

Gut microbiota: a potential target for hyperuricemia and gout DOI Creative Commons
Feiyan Zhao, Shuying Yang, Lai‐Yu Kwok

и другие.

Deleted Journal, Год журнала: 2024, Номер unknown

Опубликована: Июль 1, 2024

Modern lifestyle and diet have increased the incidence rate of uric acid (UA) metabolism-related diseases like hyperuricemia (HUA) gout, posing heavy economic burden to individual patients their families society. Uric metabolism is a complex physiological process involving kidney, intestine, other organs. A number factors together regulate UA metabolism, including genetics, diet, hormones, gut microbiota. This review summaries microbiota features in subjects with HUA therapeutic effects implementing microecological therapies (probiotics, prebiotics, or fecal transplant) that target modulate its downstream on disease. Current evidence shows these strategies are safe promising alleviate inflammation, reduce UA, restoring healthy diseases. However, most clinical data generated by animal studies. Therefore, we propose vigorous human intervention trials should be conducted future evaluate managing gout.

Язык: Английский

Процитировано

0